Same Indication

Lebrikizumab vs Montelukast

Lebrikizumab vs Montelukast: Overview

This comparison examines the pharmacological differences between Lebrikizumab and Montelukast.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Montelukast β€” 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Montelukast β€” C35H36ClNO3S.

Molecular Weight: Montelukast β€” 586.1800 g/mol.

Type: Lebrikizumab β€” Antibody; Montelukast β€” Small molecule.